论文标题
MRI中用于脑肿瘤分割的多模式CNN网络:BRATS 2022挑战解决方案
Multimodal CNN Networks for Brain Tumor Segmentation in MRI: A BraTS 2022 Challenge Solution
论文作者
论文摘要
自动分割对于脑肿瘤诊断,疾病预后以及神经胶质瘤患者的随访疗法至关重要。尽管如此,由于扫描仪和成像方案的种类繁多,对多模式MRI的胶质瘤及其子区域的准确检测非常具有挑战性。在过去的几年中,Brats挑战提供了大量的多机构MRI扫描,作为神经胶质瘤分割算法的基准。本文描述了我们对Brats 2022连续评估挑战的贡献。我们提出了一个新的深度学习框架的新合奏,即术前MRI中的自动神经胶质瘤边界检测。值得注意的是,我们的合奏模型在Brats测试数据集的最终评估中排名第一,骰子得分为0.9294、0.8788和0.8803,Hausdorf距离为5.23、13.54和12.05,分别为整个Tumor,Tumor Core和Tumor Core和Tumor,分别为5.23、13.54和12.05。 Furthermore, the proposed ensemble method ranked first in the final ranking on another unseen test dataset, namely Sub-Saharan Africa dataset, achieving mean Dice scores of 0.9737, 0.9593, and 0.9022, and HD95 of 2.66, 1.72, 3.32 for the whole tumor, tumor core, and enhancing tumor, respectively.获奖提交的Docker图像可在(https://hub.docker.com/r/razeineldin/camed22)上公开获取。
Automatic segmentation is essential for the brain tumor diagnosis, disease prognosis, and follow-up therapy of patients with gliomas. Still, accurate detection of gliomas and their sub-regions in multimodal MRI is very challenging due to the variety of scanners and imaging protocols. Over the last years, the BraTS Challenge has provided a large number of multi-institutional MRI scans as a benchmark for glioma segmentation algorithms. This paper describes our contribution to the BraTS 2022 Continuous Evaluation challenge. We propose a new ensemble of multiple deep learning frameworks namely, DeepSeg, nnU-Net, and DeepSCAN for automatic glioma boundaries detection in pre-operative MRI. It is worth noting that our ensemble models took first place in the final evaluation on the BraTS testing dataset with Dice scores of 0.9294, 0.8788, and 0.8803, and Hausdorf distance of 5.23, 13.54, and 12.05, for the whole tumor, tumor core, and enhancing tumor, respectively. Furthermore, the proposed ensemble method ranked first in the final ranking on another unseen test dataset, namely Sub-Saharan Africa dataset, achieving mean Dice scores of 0.9737, 0.9593, and 0.9022, and HD95 of 2.66, 1.72, 3.32 for the whole tumor, tumor core, and enhancing tumor, respectively. The docker image for the winning submission is publicly available at (https://hub.docker.com/r/razeineldin/camed22).